HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

L 30 (L-30)

a sodium channel blocker; structure in first source
Also Known As:
L-30; L 30, hydrochloride
Networked: 75 relevant articles (2 outcomes, 1 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Bao, Qiyu: 1 article (01/2022)
2. Cai, Shujing: 1 article (01/2022)
3. Chen, Bo: 1 article (01/2022)
4. Chen, Wei: 1 article (01/2022)
5. Domellöf, Magnus: 1 article (01/2022)
6. Ji, Yongan: 1 article (01/2022)
7. Li, Changchong: 1 article (01/2022)
8. Li, Qiaoling: 1 article (01/2022)
9. Sjöström, Elisabeth Stoltz: 1 article (01/2022)
10. Späth, Cornelia: 1 article (01/2022)

Related Diseases

1. Myocardial Infarction
02/01/2003 - "At the baseline, Group L had a significantly lower LVEF (H 55+/-7 vs. M 40+/-3 vs. L 30+/-3%, P<0.05), significantly greater LVDd (49+/-6 vs. 52+/-7 vs. 56+/-6 mm, P<0.05), and a higher incidence of anterior infarction (P<0.01) compared with Groups H and M, whereas there were no difference in age, sex, coronary risk factors, the incidence of multivessel disease, prior myocardial infarction, peak WR or peak VO(2) among the three groups. "
01/01/1993 - "Admission predictors of the occurrence of an adverse event included a history of bypass surgery, emergent surgery, a history of chronic obstructive pulmonary disease, the presence of an infiltrate on admission chest radiograph, a pulse of 110 beats/min or more, age, blood urea nitrogen of 10.7 mmol/L (30 mg/dL) or more, acute myocardial infarction at admission, and a history of myocardial infarction; the presence of one- or two-vessel disease was negatively associated with the occurrence of an adverse event. "
03/01/1983 - "Myocardial infarction was assessed in 175 patients admitted to our coronary-care unit, with respect to sensitivity (100%) and specificity (98%) when a decision point of 100 U/L (30 degrees C) was chosen for total creatine kinase activity (dithiothreitol-activated) and 6 U/L (30 degrees C) for the isoenzyme (by immunoinhibition). "
07/01/2012 - "Among those with myocardial infarction with and without lipid-lowering therapy, 41% and 84%, respectively, had not reached a total cholesterol < 4.5 mmol/l, 30% and 79%, respectively, had not reached a low-density lipoprotein cholesterol < 2.5 mmol/l, and 46% and 48%, respectively, had not reached triglycerides < 1.7 mmol/l. "
2. Insulin Resistance
3. Infarction (Infarctions)
4. Neoplasms (Cancer)
5. Body Weight (Weight, Body)

Related Drugs and Biologics

1. Glucose (Dextrose)
2. M40 (M 40)
3. Hypoglycemic Agents (Hypoglycemics)
4. dextran - saline drug combination (L-410)
5. hydroxide ion
6. Vitamin D
7. Proteins (Proteins, Gene)
8. Urea (Carbamide)
9. Creatinine
10. Creatine Kinase (Creatine Phosphokinase)

Related Therapies and Procedures

1. Therapeutics
2. Drug Therapy (Chemotherapy)
3. Platelet Transfusion (Blood Platelet Transfusions)
4. Cardiopulmonary Bypass (Heart-Lung Bypass)
5. Blood Component Removal (Apheresis)